Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 25 04 2017
revised: 22 11 2017
accepted: 23 08 2018
pubmed: 31 8 2018
medline: 31 3 2020
entrez: 31 8 2018
Statut: ppublish

Résumé

Cyclic adenosine monophosphate (cAMP) regulates cardiac excitation-contraction coupling by acting in microdomains associated with sarcolemmal ion channels. However, local real time cAMP dynamics in such microdomains has not been visualized before. We sought to directly monitor cAMP in a microdomain formed around sodium-potassium ATPase (NKA) in healthy and failing cardiomyocytes and to better understand alterations of cAMP compartmentation in heart failure. A novel Förster resonance energy transfer (FRET)-based biosensor termed phospholemman (PLM)-Epac1 was developed by fusing a highly sensitive cAMP sensor Epac1-camps to the C-terminus of PLM. Live cell imaging in PLM-Epac1 and Epac1-camps expressing adult rat ventricular myocytes revealed extensive regulation of NKA/PLM microdomain-associated cAMP levels by β2-adrenoceptors (β2-ARs). Local cAMP pools stimulated by these receptors were tightly controlled by phosphodiesterase (PDE) type 3. In chronic heart failure following myocardial infarction, dramatic reduction of the microdomain-specific β2-AR/cAMP signals and β2-AR dependent PLM phosphorylation was accompanied by a pronounced loss of local PDE3 and an increase in PDE2 effects. NKA/PLM complex forms a distinct cAMP microdomain which is directly regulated by β2-ARs and is under predominant control by PDE3. In heart failure, local changes in PDE repertoire result in blunted β2-AR signalling to cAMP in the vicinity of PLM.

Identifiants

pubmed: 30165515
pii: 5079901
doi: 10.1093/cvr/cvy221
pmc: PMC6383061
doi:

Substances chimiques

Adrb2 protein, rat 0
Adrenergic beta-Agonists 0
Guanine Nucleotide Exchange Factors 0
Membrane Proteins 0
Phosphoproteins 0
Receptors, Adrenergic, beta-2 0
phospholemman 135541-82-1
Cyclic AMP E0399OZS9N
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
Cyclic Nucleotide Phosphodiesterases, Type 2 EC 3.1.4.17
Cyclic Nucleotide Phosphodiesterases, Type 3 EC 3.1.4.17
Atp1a1 protein, rat EC 3.6.1.-
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

546-555

Subventions

Organisme : British Heart Foundation
ID : RG/12/18/30088
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/17/13/33173
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 109604/Z/15/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/68/30988
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L006855/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/17/15/33106
Pays : United Kingdom

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Références

Am J Physiol Regul Integr Comp Physiol. 2016 Jun 1;310(11):R1312-21
pubmed: 27147617
Biochem J. 1994 Dec 1;304 ( Pt 2):635-40
pubmed: 7999001
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20756-61
pubmed: 23185013
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11476-81
pubmed: 12169672
Circulation. 2002 Jul 23;106(4):447-53
pubmed: 12135944
J Biol Chem. 1991 Jun 15;266(17):11126-30
pubmed: 1710217
Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H225-33
pubmed: 12388273
Sci STKE. 2001 Oct 16;2001(104):re15
pubmed: 11604549
Acta Physiol (Oxf). 2013 Apr;207(4):650-62
pubmed: 23383621
IUBMB Life. 2009 Mar;61(3):215-21
pubmed: 19243007
J Biol Chem. 2013 May 10;288(19):13808-20
pubmed: 23532852
Cardiovasc Res. 2017 Jun 1;113(7):770-782
pubmed: 28505272
Nat Protoc. 2011 Apr;6(4):427-38
pubmed: 21412271
Clin Transl Sci. 2010 Aug;3(4):189-96
pubmed: 20718822
J Appl Physiol (1985). 2015 Sep 1;119(5):475-86
pubmed: 26159759
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6854-9
pubmed: 19342485
Biochim Biophys Acta. 1957 Feb;23(2):394-401
pubmed: 13412736
J Am Coll Cardiol. 2013 Oct 22;62(17):1596-606
pubmed: 23810893
Physiol Rep. 2015 Aug;3(8):
pubmed: 26296772
Am J Physiol. 1977 May;232(5):C165-73
pubmed: 324293
Gene. 2001 Jun 13;271(1):69-79
pubmed: 11410367
J Biol Chem. 2004 Sep 3;279(36):37215-8
pubmed: 15231839
Am J Physiol Cell Physiol. 2009 Jun;296(6):C1346-55
pubmed: 19339511
J Mol Cell Cardiol. 2003 Jan;35(1):5-25
pubmed: 12623296
Cardiovasc Res. 2005 Jan 1;65(1):93-103
pubmed: 15621037
Circ Res. 2008 Aug 1;103(3):279-88
pubmed: 18599868
J Biol Chem. 2011 Oct 14;286(41):36020-31
pubmed: 21868384
Circ Res. 2003 Oct 17;93(8):700-9
pubmed: 14563709
Circ Res. 2012 Aug 3;111(4):482-92
pubmed: 22859670
J Biol Chem. 2004 Dec 10;279(50):52095-105
pubmed: 15466415
J Mol Cell Cardiol. 2015 Apr;81:34-45
pubmed: 25640161
Cardiovasc Res. 2014 Oct 1;104(1):72-82
pubmed: 25103111
J Biol Chem. 2005 Sep 2;280(35):31036-44
pubmed: 15961389
Science. 2010 Mar 26;327(5973):1653-7
pubmed: 20185685
Nat Commun. 2015 Apr 28;6:6965
pubmed: 25917898
Circ Res. 2006 Dec 8;99(12):1376-83
pubmed: 17095720
Circulation. 2008 Apr 8;117(14):1849-55
pubmed: 18362230
Circ Res. 2006 Nov 10;99(10):1084-91
pubmed: 17038640
Am J Physiol Renal Physiol. 2003 Jul;285(1):F121-9
pubmed: 12657562
Circ Res. 2015 Apr 10;116(8):1304-11
pubmed: 25688144
Drugs. 2003;63(5):439-52
pubmed: 12600224

Auteurs

Zeynep Bastug-Özel (Z)

Clinic of Cardiology and Heart Research Center, University Medical Center Göttingen, Göttingen, Germany.
Cardiovascular Division, King's College London, London, UK.

Peter T Wright (PT)

National Heart and Lung Institute, Imperial College London, London, UK.

Axel E Kraft (AE)

Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.
German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/Lübeck, Martinistr. 52, D-20246 Hamburg, Germany.

Davor Pavlovic (D)

Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.

Jacqueline Howie (J)

Division of Cardiovascular and Diabetes Medicine, University of Dundee, Dundee, UK.

Alexander Froese (A)

Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.
German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/Lübeck, Martinistr. 52, D-20246 Hamburg, Germany.

William Fuller (W)

Division of Cardiovascular and Diabetes Medicine, University of Dundee, Dundee, UK.

Julia Gorelik (J)

National Heart and Lung Institute, Imperial College London, London, UK.

Michael J Shattock (MJ)

Cardiovascular Division, King's College London, London, UK.

Viacheslav O Nikolaev (VO)

Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany.
German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/Lübeck, Martinistr. 52, D-20246 Hamburg, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH